Inventor · disambiguated record
Sharon Rosenzweig-Lipson
Also filed as: ROSENZWEIG-LIPSON SHARON · ROSENZWEIG-LIPSON SHARON J · ROSENZWEIG-LIPSON SHARON JOY
15 granted patents·27 pending applications·147 citations·filing 2001–2023
93Inventor score
Top patents by PatentIndex Score
42 records- 0188US6586436B2Serotonergic agentsWYETH CORP·Filed 2002·Granted Jul 1, 2003·23 cites·2 claims
- 0288US6469007B2Serotonergic agentsWYETH CORP·Filed 2001·Granted Oct 22, 2002·24 cites·7 claims
- 0387US6589986B2Methods of treating anxiety disordersWYETH CORP·Filed 2001·Granted Jul 8, 2003·34 cites·7 claims
- 0484US7425558B2Serotonergic agents for treating sexual dysfunctionWYETH CORP·Filed 2006·Granted Sep 16, 2008·4 cites·1 claims
- 0583US10925834B2Extended release pharmaceutical compositions of levetiracetamAGENEBIO INC·Filed 2016·Granted Feb 23, 2021·2 cites·14 claims
- 0682US7816362B2Serotonergic agentsWYETH LLC·Filed 2009·Granted Oct 19, 2010·4 cites·2 claims
- 0781US7026320B2Serotonergic agentsWYETH CORP·Filed 2003·Granted Apr 11, 2006·10 cites·2 claims
- 0879US7271163B2Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivativesWYETH CORP·Filed 2004·Granted Sep 18, 2007·9 cites·17 claims
- 0979US6777407B2Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivativesWYETH CORP·Filed 2001·Granted Aug 17, 2004·10 cites·24 claims
- 1073US7396857B2Therapeutic combinations for the treatment or prevention of depressionWYETH CORP·Filed 2006·Granted Jul 8, 2008·4 cites·16 claims
- 1173US7262336B2Transgenic animalWYETH CORP·Filed 2001·Granted Aug 28, 2007·14 cites·24 claims
- 1273US6894053B2Serotonergic agents with long-acting in vivo effectsWYETH CORP·Filed 2003·Granted May 17, 2005·5 cites·4 claims
- 1373US2023172862A1Extended release pharmaceutical compositions of levetiracetamAGENEBIO INC·Filed 2022·Application pending·0 cites
- 1472US6476032B22,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5(6H)one derivativesWYETH CORP·Filed 2001·Granted Nov 5, 2002·2 cites·11 claims
- 1567US6696450B2Serotonergic agents with long-acting in vivo effectsWYETH CORP·Filed 2002·Granted Feb 24, 2004·2 cites·15 claims
- 1666US2021346299A1Extended release pharmaceutical compositions of levetiracetamAGENEBIO INC·Filed 2020·Application pending·0 cites
- 1764US2008070925A1Serotonergic agents for treating sexual dysfunctionSUKOFF RIZZO STACEY J·Filed 2007·Application pending·0 cites
- 1863US2023270753A1Combinations of gabaa alpha 5 agonists and sv2a inhibitors and methods of using in the treatment of cognitive impairmentAGENEBIO INC·Filed 2021·Application pending·0 cites
- 1963US2022062296A1Combinations of gabaa alpha 5 agonists and sv2a inhibitors and methods of using in the treatment of cognitive impairmentAGENEBIO INC·Filed 2021·Application pending·0 cites
- 2061US2006287335A1Serotonergic agents for treating sexual dysfunctionWYETH CORP·Filed 2006·Application pending·0 cites
- 2159US2008009480A1CYCLOPENTA[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVESWYETH CORP·Filed 2007·Application pending·0 cites
- 2259US2025228820A1Methods for preventing or slowing the progression of cognitive decline or impairment in subjects displaying normal cognitive performanceAGENEBIO INC·Filed 2023·Application pending·0 cites
- 2356US2007167438A1Treatment of substance abuseWYETH CORP·Filed 2007·Application pending·0 cites
- 2455US2008168571A1Transgenic animalWYETH A DELAWARE CORP·Filed 2007·Application pending·0 cites
- 2554US10159648B2Extended release pharmaceutical compositions of levetiracetamAGENEBIO INC·Filed 2016·Granted Dec 25, 2018·0 cites·25 claims
- 2653US2005202412A1Serotonergic agents with long-acting in vivo effectsWYETH CORP·Filed 2005·Application pending·0 cites
- 2752US2006223824A1Serotonergic agentsWYETH CORP·Filed 2006·Application pending·0 cites
- 2849US2008269321A1Therapeutic Combinations for the Treatment or Prevention of DepressionWYETH CORP·Filed 2008·Application pending·0 cites
- 2946US2007225334A1Methods for treating cognitive and other disordersWYETH CORP·Filed 2007·Application pending·0 cites
- 3046US2007225278A1Methods for treating cognitive and other disordersWYETH CORP·Filed 2007·Application pending·0 cites
- 3146US2007238725A1Therapeutic combinations for the treatment or prevention of psychotic disordersWYETH CORP·Filed 2007·Application pending·0 cites
- 3246US2007225279A1Therapeutic combinations for the treatment of depressionWYETH CORP·Filed 2007·Application pending·0 cites
- 3346US2007225277A1Treatment of painWYETH CORP·Filed 2007·Application pending·0 cites
- 3445US2003024001A1Knock in transgenic mammal containing a non-functional N-terminus of Kv beta 1.1 subunitWYETH CORP·Filed 2002·Application pending·0 cites
- 3544US2006258711A1Treatment of drug abuseWYETH CORP·Filed 2006·Application pending·0 cites
- 3644US2006258713A1Treatment of painWYETH CORP·Filed 2006·Application pending·0 cites
- 3744US2006258639A1Therapeutic combinations for the treatment or prevention of psychotic disordersWYETH CORP·Filed 2006·Application pending·0 cites
- 3844US2008161260A1Methods for Detecting and Quantifying Cell Proliferation In VivoWYETH CORP·Filed 2007·Application pending·0 cites
- 3943US2008032965A1Method for enhancing cognitive functionHIRST WARREN D·Filed 2007·Application pending·0 cites
- 4041US2007117794A1Methods of treatment using oxytocin receptor agonistsWYETH CORP·Filed 2006·Application pending·0 cites
- 4140US2006276394A1Methods and compositions for treating neurological disordersWYETH CORP·Filed 2006·Application pending·0 cites
- 4235US2006263299A1Effect of substances on sexual functionSUKOFF RIZZO STACEY J·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →